Natural Product: NPC470363

Natural Product IDNPC470363
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
 1-O-(2,12-Dimethyltridecanoyl)-Sn-Glycerol
IUPAC Name [(2S)-2,3-dihydroxypropyl] 2,12-dimethyltridecanoate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2021366
PubChem CID 10958071
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000175] Glycerolipids
        • [CHEMONTID:0003808] Monoradylglycerols
          • [CHEMONTID:0001133] Monoacylglycerols
            • [CHEMONTID:0001597] 1-monoacylglycerols

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LPXGHYUNYHADCZ-DJNXLDHESA-N
Standard InCHI InChI=1S/C18H36O4/c1-15(2)11-9-7-5-4-6-8-10-12-16(3)18(21)22-14-17(20)13-19/h15-17,19-20H,4-14H2,1-3H3/t16?,17-/m0/s1
SMILES CC(C)CCCCCCCCCC(C)C(=O)OCC(CO)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   316.26 Volume:   352.409
?
Van der Waals volume.
Dense:   0.897 LogP:   4.129
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.403
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
 LogS:   -3.653
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   15.0 Rigid Bonds:   1.0
TPSA:   66.76
?
Topological Polar Surface Area.
 H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   0.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.379 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.99 Fsp3:   0.944
MCE-18:   4.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
 Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.105 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
 Green fluorescence:   0.002
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.936 Promiscuous compounds:   0.048

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.153 MDCK Permeability:   -4.738
Pgp-inhibitor:   0.0 Pgp-substrate:   0.003
PAMPA:   0.151
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
 Human Intestinal Absorption (HIA):   0.108
20% Bioavailability (F20%):   0.386 30% Bioavailability (F30%):   0.854
50% Bioavailability (F50%):   0.686

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.12 MRP1:   0.888
Plasma Protein Binding (PPB):   97.973% Volume Distribution (VD):   0.315
Fu: 2.592%
?
The fraction unbound in plasms.
 OATP1B1 inhibitor:   0.495
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.046
BSEP inhibitor:   0.023

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.046
CYP2C19-inhibitor:   0.019 CYP2C19-substrate:   0.02
CYP2C9-inhibitor:   0.63 CYP2C9-substrate:   0.071
CYP2D6-inhibitor:   0.008 CYP2D6-substrate:   0.155
CYP3A4-inhibitor:   0.724 CYP3A4-substrate:   0.86
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.978
HLM stability:   0.46
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.853 Half-life (T1/2):  0.516

ADMET: Toxicity

hERG Blockers:  0.104 hERG Blockers (10um):  0.527
Human Hepatotoxicity (H-HT):  0.452 Drug-induced Liver Injury (DILI):  0.02
AMES Toxicity:  0.466 Rat Oral Acute Toxicity:  0.024
Maximum Recommended Daily Dose:  0.071 Skin Sensitization:  0.984
Carcinogencity:  0.557 Eye Corrosion:  0.241
Eye Irritation:  0.84 Respiratory Toxicity:  0.11
Drug-induced Neurotoxicity:  0.025 Ototoxicity:  0.792
Hematotoxicity:  0.159 Drug-induced Nephrotoxicity:  0.348
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.038
A549 Cytotoxicity:  0.065 Hek293 Cytotoxicity:  0.033
BCF:   2.061
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
 IGC50:   4.875
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.078
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
 LC50FM:   5.279
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[10479342]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. (20 m depth) off Ullung Island, Korea 2001-OCT PMID[12662102]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[12713419]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[12762820]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[23465061]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[31646862]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[8946745]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[9296951]
NPO33189 Stelletta sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT148 Cell line HCT-15 Homo sapiens ED50 = 18.6 ug ml-1 PMID[12350139]
NPT81 Cell line A549 Homo sapiens ED50 = 20.0 ug ml-1 Open TG-GATES in vivo data: Hematology
NPT147 Cell line SK-MEL-2 Homo sapiens ED50 = 21.8 ug ml-1 Open TG-GATES in vivo data: Hematology
NPT574 Cell line XF498 Homo sapiens ED50 = 30.7 ug ml-1 Open TG-GATES in vivo data: Hematology
NPT146 Cell line SK-OV-3 Homo sapiens ED50 = 38.9 ug ml-1 PMID[19786608]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC470363 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6857 Remote Similarity NPC609455
0.5854 Remote Similarity NPC209327
0.5714 Remote Similarity NPC273508
0.5135 Remote Similarity NPC488257
0.5135 Remote Similarity NPC469937
0.5135 Remote Similarity NPC94699
0.5135 Remote Similarity NPC320588
0.5135 Remote Similarity NPC53463
0.5102 Remote Similarity NPC330017

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470363 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data